JenniferESchwartzMDFASCO(She/Her)
Hematology • Indianapolis, INHematologic Oncology
Interim Division Chief, Hematology-Oncology, Interim Director of Stem Cell Transplantation and Cellular Therapy
Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
980 W Walnut St
C312
Indianapolis, IN 46202Phone+1 317-274-0843Fax+1 317-962-0861
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2000 - 2003
McGill University Faculty of MedicineClass of 1997
Certifications & Licensure
IN State Medical License 2003 - 2025
PA State Medical License 2001 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 6 citationsImmune-Based Therapeutic Interventions for Acute Myeloid Leukemia.Fabiana Perna, Manuel R Espinoza-Gutarra, Giuseppe Bombaci, Sherif S Farag, Jennifer E Schwartz
Cancer Treatment and Research. 2022-01-01 - 83 citationsDoes Linezolid Cause Lactic Acidosis by Inhibiting Mitochondrial Protein SynthesisLluis Palenzuela, Noah M. Hahn, Robert Nelson, Janet N. Arno, Carol Schobert
Clinical Infectious Diseases. 2005-06-15 - 33 citationsDipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host DiseaseSherif S. Farag, Mohammad Abu Zaid, Jennifer E. Schwartz, Teresa C Thakrar, Ann J Blakley
The New England Journal of Medicine. 2021-01-06
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
